September 16, 2022
With Microsoft 365, Teams, Zoom, and other non-traditional modes of communication now the norm, Columbia partner Jarrett Coco will explore how discovery may look over the next couple of years and the legal ethical rules applicable to using artificial intelligence (“AI”) to detect Personal Health Information (“PHI”) and the AI capabilities available to assist companies.
Looking Ahead: E-Discovery Trends and the Ethical Use of Emerging ToolsHeyward is a member of the Nelson Mullins Encompass Leadership Team. She has extensive experience representing health insurance, energy, and pharmaceutical clients, including serving as lead discovery and review counsel for our Fortune 200 global pharmaceutical client since 2008. She advises clients on complex business and litigation issues including information governance, preservation, and discovery-related issues,...
Heyward is a member of the Nelson Mullins Encompass Leadership Team. She has extensive experience representing health insurance, energy, and pharmaceutical clients, including serving as lead discovery and review counsel for our Fortune 200 global pharmaceutical client since 2008. She advises clients on complex business and litigation issues including information governance, preservation, and discovery-related issues, in addition to discovery and review counsel services. She works directly with clients regarding collection and processing of data to be reviewed, manages the relationship with review platform vendors, coordinates project ramp-up and kickoffs, monitors data flow from the client through processing and review, and oversees productions.
in addition to discovery and review counsel services. She works directly with clients regarding collection and processing of data to be reviewed, manages the relationship with review platform vendors, coordinates project ramp-up and kickoffs, monitors data flow from the client through processing and review, and oversees productions.
Heyward is a member of the Nelson Mullins Encompass Leadership Team. She has extensive experience representing health insurance, energy, and pharmaceutical clients, including serving as lead discovery and review counsel for our Fortune 200 global pharmaceutical client since 2008. She advises clients on complex business and litigation issues including information governance, preservation, and discovery-related issues,... in addition to discovery and review counsel services. She works directly with clients regarding collection and processing of data to be reviewed, manages the relationship with review platform vendors, coordinates project ramp-up and kickoffs, monitors data flow from the client through processing and review, and oversees productions.